1. Home
  2. RCMT vs ELDN Comparison

RCMT vs ELDN Comparison

Compare RCMT & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCM Technologies Inc.

RCMT

RCM Technologies Inc.

N/A

Current Price

$42.02

Market Cap

298.8M

ML Signal

N/A

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

N/A

Current Price

$2.44

Market Cap

291.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RCMT
ELDN
Founded
1971
2004
Country
United States
United States
Employees
4930
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
298.8M
291.8M
IPO Year
1997
2014

Fundamental Metrics

Financial Performance
Metric
RCMT
ELDN
Price
$42.02
$2.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
★ $45.00
$9.00
AVG Volume (30 Days)
59.8K
★ 782.3K
Earning Date
11-04-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
27.38
★ 30.67
EPS
★ 1.20
N/A
Revenue
★ $186,737,000.00
N/A
Revenue This Year
$11.47
N/A
Revenue Next Year
$10.09
N/A
P/E Ratio
$34.21
★ N/A
Revenue Growth
★ 5.83
N/A
52 Week Low
$17.26
$1.35
52 Week High
$43.09
$4.60

Technical Indicators

Market Signals
Indicator
RCMT
ELDN
Relative Strength Index (RSI) 58.26 30.37
Support Level $38.84 $1.96
Resistance Level $42.54 $3.18
Average True Range (ATR) 1.04 0.15
MACD -0.24 0.00
Stochastic Oscillator 58.23 3.33

Price Performance

Historical Comparison
RCMT
ELDN

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions, including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, and Europe.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Share on Social Networks: